Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vigabatrin: Preliminary Phase II data

Top-line data from an investigator-run Mexican Phase II trial in 103 patients showed that

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE